Kah Hin Tan

Efficacy and safety of celgosivir in patients with dengue fever (CELADEN): a phase 1b, randomised, double-blind, placebo-controlled, proof-of-concept trial

Jenny G. Low, Cynthia Sung, Limin Wijaya et al. · The Lancet Infectious Diseases · 2014 · 251 citations

Pharmacy, Infectious Diseases, Pharmacology +11

Celgosivir treatment misfolds dengue virus NS1 protein, induces cellular pro-survival genes and protects against lethal challenge mouse model

Abhay P. S. Rathore, Prasad N. Paradkar, Satoru Watanabe et al. · Antiviral Research · 2011 · 165 citations

Life Sciences, Infectious Diseases, Molecular Biology +11

The Magnitude of Dengue Virus NS1 Protein Secretion Is Strain Dependent and Does Not Correlate with Severe Pathologies in the Mouse Infection Model

Satoru Watanabe, Kah Hin Tan, Abhay P. S. Rathore et al. · Journal of Virology · 2012 · 73 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +16